Picosulfate PCD Pharma Franchise Company
Cafoli Lifecare is a WHO-GMP certified Picosulfate PCD pharma franchise company offering 3 Picosulfate formulations across Syrup, Tablets. Every batch is manufactured in DCGI-approved, WHO-GMP compliant facilities and supplied to franchise partners on a monopoly basis with full promotional backing.
What is Picosulfate?
Sodium picosulfate is a stimulant laxative and a prodrug. It passes through the stomach and small intestine unchanged and is hydrolysed by colonic bacterial enzymes into its active form, which stimulates the mucosa of the large intestine to increase peristalsis and reduce water reabsorption, producing a bowel movement. It is used for constipation and for bowel preparation before colonoscopy or abdominal surgery. Compound data is available on PubChem.
Picosulfate Range Available for Franchise
Our Picosulfate portfolio comprises 3 formulations available in the following dosage forms: Syrup, Tablets. Brand names, compositions, packing and net rates are shared on request with partners holding a valid Drug License. Contact us for the current Picosulfate price list and stock position.
Therapeutic Applications of Picosulfate
Picosulfate is indicated for the short-term management of constipation — including constipation secondary to opioid analgesia, immobility, pregnancy-related changes and post-surgical recovery — and, in higher-dose combination regimens, for pre-procedure bowel cleansing. Prescribers include gastroenterologists, general surgeons, general physicians, geriatricians and paediatricians (syrup form).
Why Picosulfate is a High-Potential Molecule for Distributors
Constipation is a chronic, recurring complaint rather than an acute one — sedentary work patterns, low-fibre diets and an ageing population keep the laxative category expanding steadily in India. Picosulfate's advantage over older stimulant laxatives is that it is activated only in the colon, giving a predictable overnight effect with less upper-GI cramping, which prescribers value for elderly and post-operative patients. The syrup form also opens the paediatric and geriatric segments. For a distributor, laxatives are a repeat-purchase, low-price-point line that keeps chemists ordering monthly and complements a gastro portfolio built around PPIs, prokinetics and enzyme preparations.
Why Choose Cafoli Lifecare for Your Picosulfate Franchise
Cafoli Lifecare works with over 1000+ franchise partners across India. Partners receive monopoly rights for their district or territory, WHO-GMP certified and DCGI-approved products, complete promotional inputs (visual aids, MR bags, samples, prescription pads, gifts), transparent net rates, and dependable dispatch. Our documentation and stock support are built for distributors who want to scale without operational friction.
References
- PubChem — Sodium Picosulfate compound record (NIH / NCBI)
- MedlinePlus — Sodium Picosulfate drug information (US National Library of Medicine)
- PubMed — clinical literature on Sodium Picosulfate
Our formulations of Picosulfate find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: